FDA approves new device for blood glucose monitoring in teenagers
-
Last Update: 2020-07-08
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
the U.SFood and Drug Administration has approveda "real-time continuous blood glucose monitoring device" developedby Medtronasfor use by 7 to 17-year-oldsIt is reported that,the device has previously been approved by the U.SDrug Enforcement Administration,for diabetes adult patients blood glucose monitoringMedtronisaid in a press release that the device has been tested in clinical trials to monitor blood sugar levels in diabetics"Monitoring blood sugar is particularly difficult for adolescents, and the new device can help them keep up with their blood sugar conditions and monitor their condition," said Bruce Buckingham, director of pediatric endocrinology at Lucille PackardChildren'sHospital in the United States"
large-scale clinical trial son-in-
conducted last November by the Medtroni Division, which showed that using this blood glucose monitoring device can monitor the blood sugar of diabetics more effectively than using finger-only tests alone It is reported that the device for adults is now on sale in many countries around the world, and new devices for teenagers will soon be available (
Xinhua Provides without permission, is strictly prohibited from reprinting)
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.